Investigational Site Number :2030003

Olomouc 77900

0 studies enrolling now · 2 studies all time

What they study most

Neoplasm, Plasma Cell Myeloma Recurrent

Studies at this site

• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies — Stopped early